BACKGROUND The CAFE Study, conducted by Jeffrey Lieberman, MD, et al between 2002 and 2005, has been the subject of much comment. Carl Elliott, in particular, has written extensively on the matter, including his article The Deadly Corruption of Clinical Trials in Mother Jones. In order to address the issues involved in the CAFE study, we… Continue Reading
Antipsychotics: A Euphemism for Neurotoxins
I guess everybody knows by now that Robert Whitaker spoke at the NAMI conference in San Antonio last Saturday (June 29). You can view an outline of his speech, The Case for Selective Use of Antipsychotics here. He spoke about the fact that for people who have been assigned a “diagnosis” of “schizophrenia,” long-term outcomes… Continue Reading
Neuroleptic Drugs and Children: Wrong Focus
It is a central theme of this website that psychiatry has done, and continues to do, a great deal of damage to people it claims to help. In my opinion, the damage done by neuroleptic drugs is among the most severe. The increasing use of these products ought to be a huge cause for concern…. Continue Reading
Reduction in Neuroleptic Drugs Leads to Better Outcomes: Surprise?
BACKGROUND Mad in America ran an article (Reduction/Discontinuation of Antipsychotics Produces Higher Long-Term Recovery) on July 3, describing a piece of research on this topic which had been done in Holland. The original article, by Lex Wunderink, MD PhD et al, was published in the Journal of the American Medical Association Psychiatry (JAMA-P). You can see… Continue Reading
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- 11
- Next Page »